Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China. Smartlipo MPX is the world's signature brand for precision body contouring; Affirm provides a complete skin rejuvenation solution that targets all layers of photodamaged and aged skin.
"These approvals for Smartlipo MPX and Affirm further our initiative to expand in the Asia Pacific region as part of our international growth strategy," said Cynosure President and Chief Executive Officer Michael Davin. "We believe that the increasing economic prosperity of the middle class in these countries is creating a vibrant base of aesthetically conscious consumers and a corresponding demand from practitioners eager to be trained on new procedures and techniques. By having already established a direct sales presence in China and Korea, we believe we are well positioned to capitalize on opportunities through new product introductions in these dynamic markets."